ZNF266 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)

Cat. No.
51395111
Unit
3 x 1.0 µg
Price
$265.00

Lead Time
3 to 4 weeks
Cat. No. 51395111
Name ZNF266 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)
Unit 3 x 1.0 µg
Description abm's Knockout sgRNA vectors and viruses are ready to use in your CRISPR Gene Knockout experiment. These vector and virus products come as a set of three sgRNA targets which are designed to guide Cas9 to cleave exonic gDNA resulting in frameshift mutations and ultimately gene knockout. Available constructs include All-in-One (Cas9 and sgRNA expression) and sgRNA only (no Cas9 expression) – navigate to Custom Option to select the latter. Our CRISPR vectors and viruses are also available in a variety of formats including Lentivirus, AAV and Non-Viral.
Gene Name ZNF266
Gene Full Name zinc finger protein 266
Alias HZF1
Accession Number NM_006631.4
NCBI Gene ID 10781
Species Human
Vector Map pLenti-U6-sgRNA-SFFV-Cas9-2A-Puro (click blue link to view)
System Lentiviral Vector
Target Sequence Sequence available upon placing order
Storage Condition -20°C or below
QC Restriction Enzyme Digest and Sequencing
Guarantee ABM guarantees that at least one out of the three sgRNA Lentiviral constructs purchased in a set designed to be used with Cas9 Nuclease will result in complete gene knockout in over 50% of cells at 1 week after successful transduction and drug selection due to frameshift mutation. The gene knockout efficiency can be quickly examined by Surveyor assay and confirmed by Sanger sequencing or other functional assays. If in extremely rare cases that significant knockout was not achieved, we would provide a one-time replacement of three new constructs with alternative sgRNA sequences, or a one-time discounted replacement of a sgRNA lentivirus set with alternative sgRNA sequences. To qualify for this replacement, customers must provide Surveyor assay data. Before sending your inquiry, please make sure you have optimized your experiments as far as possible, this includes (where applicable) increasing your MOI (up to 10) and the duration of infection (up to 72 hours), and carrying out clone screening before assaying for knockout. Please also provide data to show that a reporter lentivirus was used to show that you have optimized the MOI to use on your target cell line. For vector transfection, you will need to prove that there is good enough vector transfection by qPCR on Cas9 or Puro for the 'All-in-One' vectors, qPCR on Neomycin for constructs containing only the sgRNA, or successful puromycin/neomycin selection. In addition, please provide Surveyor Assay or Sanger Sequencing data on at least 20 isolated clones. ABM limits its obligation and liability for the success of this technology to providing one free replacement of any sgRNA lentivector set product only or one discounted replacement sgRNA lentivirus set. The replacement set will not be covered by the same guarantee. If these constructs are also considered to be ineffective then it is most likely due to unknown reasons. The one-time replacement guarantee cannot be applied for sgRNA lentivectors that are ordered as an individual target and not in a set of three.
Caution This product is for research use only and is not intended for therapeutic or diagnostic applications. Please contact a technical service representative for more information.
Material Citation If use of this material results in a scientific publication, please cite the material in the following manner: Applied Biological Materials Inc, Cat. No. 51395111
Print & Download Datasheet
There are no references for this product yet!
This product has no review yet.
Other ZNF266 Products
ZNF266 Human

ZNF266 Lentiviral Vector
ZNF266 AAV Vector
ZNF266 Adenovirus Vector
ZNF266 Protein Vector
ZNF266 ORF Vector
ZNF266 siRNA Vector
ZNF266 miRNA Vector
ZNF266 3'UTR Vector
ZNF266 CRISPR Knockout Vector
ZNF266 CRISPR Activation Vector
ZNF266 Control Vectors & Viruses Vector
ZNF266 circRNA Vector
ZNF266 Internal Vector